Wuhan and ePlay Announce Strategic Partnership to
Create New Medical Cannabis App
Dr. Anna, in new augmented reality app, helps retail,
educate, and inform cannabis customers.
Toronto, Canada -- October 4,
2018 -- InvestorsHub NewsWire -- Wuhan General Group (China),
Inc. (OTC:WUHN)
is delighted to
announce a new exclusive strategic partnership agreement signed
today with ePlay Digital
Inc. (CSE:EPY) to utilize
Mobvovivo's
Augmented Reality
(AR) platform in education, mobile product
information, and e-commerce to support medical cannabis and
cannabidiol (CBD) product marketing and sales. The companies will
work together to create the Dr. Anna MD app - A
Practical Guide to Cannabis.
Wuhan recently
announced the appointment of Dr. Anna Morera Leralta, ("Dr. Anna") as the
company's chief medical officer (CMO). Dr. Anna is a researcher,
thought leader and medical practitioner in the integrative medicine
and
medical cannabis fields.
"Augmented
Reality will help people learn about and easily understand the
medical benefits of CBD and related cannabis products directly on
their mobile phones," says Dr. Anna
Morera
Leralta, medical
doctor, CMO of Wuhan. "Ad
vancing
the community's insight of cannabis and cannabinoids, and
ultimately providing society with alternative options and best
practices is badly needed."
The
Dr. Anna MD app will allow
users to operate
their iPhone and Android cameras to get further information about
cannabis products while driving advertising revenue, sales, and
data analytics. Information about safety, efficacy, and
effectiveness of cannabis and cannabinoids in pain,
symptom
management, and other conditions, will be available for products
worldwide. Manufacturers and retailers will utilize Dr.
Anna MD for
training staff, marketing, and as a service offered to their retail
and e-commerce customers. Customers and patients
will rely on Dr.
Anna MD to better understand the benefits, safety, and performance
of an exploding number of new products.
"Ultimately,
people will get to know Dr. Anna, as she appears in Augmented
Reality, as a great and trusted source of information
for
cannabis and
cannabinoids," says Trevor Doerksen, CEO
of ePlay Digital. "In situations where
packaging and advertising is limited, users will have access to
more information from Dr. Anna by simply pointing their iPhone or
Android phone at products."
In Canada, California, and
other jurisdictions, governments require utilitarian, plain
Cannabis packaging and place heavy restrictions on Cannabis
advertising. Dr. Anna will help cannabis consumers learn more about
products and where to buy them in real time through iPhone and Android
smartphones. As a trusted source in an emerging marketplace more
information will appear through interactive video and AR when
customers point their camera to any product label or advertising at
retail or on a website.
The
global
legal cannabis market is expected to reach USD 146.4 billion by end
of 2025[1]. Growing adoption of
cannabis in several medical applications such as cancer, mental
disorders, chronic pain and others is expected to propel revenue
growth. Marketing and advertising budgets will be
funneled into approved approaches such as education and
technologies that can deliver more information about products to
consumers easily.
About ePlay
ePlay
Digital Inc. is a
mobile game creator and publisher specializing in sports and
entertainment augmented reality titles, including their new
flagship title Big Shot Basketball. ePlay is operated by an
award-winning team of sports, gaming and eSports leaders as well as
broadcast and digital technology industry experts, software engineers
and athletes who have brought dozens of game titles to market for
companies including Time Warner Cable, ESPN, Sony Pictures, AXS TV,
Intel, AXN, Fiat, CBS, and others.
E-mail:
info@eplaydigital.com
Website:
www.eplaydigital.com
About Wuhan General Group (China),
Inc.
Wuhan General
Group (China), Inc., is a Nevada-based investment company focus in
emerging technology and in medical cannabis and cannabidiol (CBD)
sectors. Through acquisitions, Wuhan will enter the international
146.4 billion growing cannabis market for the medical applications
such as cancer, mental disorders, chronic pain, and others is
expected to propel revenue growth in Canada, the United States, and
Europe.
For further information please contact:
Publicly traded
company (OTC
Pink:
WUHN)
Website:
www.wuhn.org
Public
Relations
Telephone:
(514) 928-7368
E-mail: info@wuhn.org
Forward-Looking Statements
Safe Harbour
Statement - In addition to historical information, this press
release may contain statements that constitute forward-looking
statements within the meaning of the Securities Act of 1933 and the
Securities Exchange Act of 1934, as amended by the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements contained in this press release include the intent,
belief, or expectations of the Company and members of its
management team with respect to the Company's future business
operations and the assumptions upon which such statements are
based. Prospective investors are cautioned that any such
forward-looking statements are not guarantees of future
performance, and involve risks and uncertainties and that actual
results may differ materially from those contemplated by such
forward-looking statements. Factors that could cause these
differences include, but are not limited to, failure to complete
anticipated sales under negotiations, lack of revenue growth,
client discontinuances, failure to realize improvements in
performance, efficiency and profitability, and adverse developments
with respect to litigation or increased litigation costs, the
operation or performance of the Company's business units or the
market price of its common stock. Additional factors that could
cause actual results to differ materially from those contemplated
within this press release can also be found on the Company's
website. The Company disclaims any responsibility to update any
forward-looking statements.
Source: Wuhan General
Group (China), Inc